2-imino-4-(thio) oxo-5-poly cyclovinylazolines for use as P13 kinase ihibitors

Details for Australian Patent Application No. 2004260836 (hide)

Owner Merck Serono SA

Inventors Covini, David; Shaw, Jeffrey; Church, Dennis; Rueckle, Thomas

Agent Griffith Hack

Pub. Number AU-B-2004260836

PCT Pub. Number WO2005/011686

Priority 03102313.8 28.07.03 EP

Filing date 27 July 2004

Wipo publication date 10 February 2005

Acceptance publication date 11 February 2010

International Classifications

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

C07D 417/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

12 January 2006 PCT application entered the National Phase

  PCT publication WO2005/011686 Priority application(s): WO2005/011686

25 October 2007 Assignment before Grant

  Applied Research Systems ARS Holding N.V. The application has been assigned to Laboratoires Serono SA

30 April 2009 Alteration of Name

  The name of the applicant has been altered to Merck Serono SA

11 February 2010 Application Accepted

  Published as AU-B-2004260836

10 June 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004260837-2-methoxymethyl-3-(3,4-dichlorophenyl) -8-azabicyclo[3.2.1]octane tartrate salts

2004260835-Use of soluble CD164 in inflammatory and/or autoimmune disorders